The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake

Journal of Lipid Research

Volumn 43, Issue 11, 2002, Pages 1890-1898

  Webb, Nancy R ^a   Cai, Lei ^a   Ziemba, Kristine S ^a   Yu, Jin ^a   Kindy, Mark S ^a   Van Der Westhuyzen, Deneys R ^a   De Beer, Frederick C ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

ABCA1; Adenovirus; Lipoprotein; Mouse; Reverse cholesterol transport; Scavenger receptor

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; ABC TRANSPORTER; ABC TRANSPORTER A1; CD36 ANTIGEN; CHOLESTEROL; IMMUNOGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; SCARB1 PROTEIN, HUMAN; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR B;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; HUMAN; LIPID ANALYSIS; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; GENE DELETION; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; PARTICLE SIZE;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; GENE DELETION; HUMANS; INJECTIONS, INTRAVENOUS; LIPID METABOLISM; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARTICLE SIZE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B;

EID: 0036847074     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200173-JLR200     Document Type: Article

References (33)

1. Fidge, N., P. Nestel, M. Ishikawa, T. Reardon, and T. Billington. 1980. Turnover of apoproteins A-I and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals. Metabolism. 29: 643-653.
2. Schaefer, E. J., L. A. Zech, L. L. Jenkins, T.J. Bronzert, E.A. Rubalcaba, R. T. Lindgren, R. L. Aamodt, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res 23: 850-862.
3. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1991. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J. Clin. Invest. 87: 536-544.
4. Brinton, E. A., A. Eisenberg, and J. L. Breslow. 1989. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 84: 262-269.
5. Rader, D. J., K. Ikewaki, N. Duverger, I. Feuerstein, L. A. Zech, W. Connor, and H. B. Brewer, Jr. 1993. Markedly decreased plasma high density lipoprotein levels without premature coronary atherosclerosis caused by rapid catabolism of apolipoproteins A-I and A-II. Lancet. 342: 1455-1458.
6. Ikewaki, K., D. J. Rader, T. Sakamoto, M. Nishiwaki, N. Wakimoto, J. Schaefer, T. Ishikawa, T. Fairwell, L. Zech, H. Nakamura, M. Nagano, and H. B. Brewer, Jr. 1993. Delayed catabolism of high density, lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J. Clin. Invest. 92: 1650-1658.
7. Rader, D. J., K. Ikewaki, N. Duverger, H. Schmidt, H. Pritchard, J. Frohlich, M. Clerc, M. F. Dumon, T. Fairwell, L. Zech, S. Santamarino-Fojo, and H. B. Brewer, Jr. 1994. Rapid catabolism of apolipoprotein A-II and high density lipoproteins containing apoA-II in classic LCAT deficiency and fish-eye disease. J. Clin. Invest. 93: 321-330.
8. Kozyraki, R., J. Fyfe, M. Kristiansen, C. Gerdes, C. Jacobsen, S. Cui, E. I. Christensen, M. Aminoff, A. de la Chapelle, R. Krahe, P.J. Verroust, and S. K. Moestrup. 1999. The intrinsic factor-vitamin B12 receptor, cubilin, is a high affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat. Med. 5: 656-661.
9. Hammad, S. M., S. Sefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer, Jr., and W. S. Argraves. 1999. Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis. Proc. Natl. Acad. Sci. USA. 96: 10158-10163.
10. Kozarsky, K. F., M. H. Donahee, A. Rigotti, S. N. Iqbal, E. R. Edelman, and M. Krieger. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature. 387: 414-417.
11. Wang, N.,T Arai, Y. Ji, F. Rinninger, and A. R. Tall. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein apoB, low density, lipoprotein apoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
12. Ueda, Y., L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B Type I transgenic mice. J. Biol. Chem. 274: 7165-7171.
13. 2 promotes SR-BI interaction and accelerates HDL metabolism. J. Lipid Res. 41: 1849-1857.
14. Strachan, A. F., F. C. de Beer, D. R. van der Westhuyzen, and G. A. Coetzee. 1988. Identification of three isoform patterns of human serum amyloid A protein. Biochem. J. 250: 203-207.
15. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoproteins. Biochim. Biophys. Acta. 260: 212-221.
16. 125I-dilactitol tyramine. J. Biol. Chem. 260: 14564-14570.
17. Rinninger, F., M. Brundert, S. Jackle, T. Kaiser, and H. Greten. 1995. Selective uptake of low-density lipoprotein-associated cholesteryl esters by human fibroblasts, human HepG2 hepatoma cells and J7743 macrophages in culture. Biochim. Biophys. Acta. 1255: 141-153.
18. Lowry, O. H., N.J. Rosebrough, A. L. Farr, and B.J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
19. Webb, N. R., P. M. Connell, G. A. Graf, E.J. Smart, W.J.S. de Villiers, E C. de Beer, and D. R. van der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273: 15241-15248.
20. Strobel, J. L., J. W. Baynes, and S. R. Thorpe. 1985. 125I-glycoconjugate labels for identifying sites of protein catabolism in vivo: Effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation. Arch. Biochem. Biophys. 240:635-645.
21. Meyer, B.J., Y. C. Ha, and P. J. Barter. 1989. Effects of experimental hypothyroidism on the distribution of lipids and lipoproteins in the plasma of rats. Biochim. Biophys. Acta. 1004: 73-79.
22. Silverman, D. I., G. S. Ginsberg, and R. C. Pasternak. 1993. High density lipoprotein subfractions. Am. J. Med. 94: 636-645.
23. Graf, G. A., P. M. Connell, D. R. van der Westhuyzen, and E. J. Smart. 1999. The class B, type I scavenger receptor promotes the selective uptake of high density lipoprotein cholesterol esters into caveolae. J. Bio. Chem. 274: 12043-12048.
24. Francis, G. A., R. H. Knoop, and J. F. Oram. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96: 78-87.
25. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. F. Oram. 1999. The Tangier disease product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-31.
26. de Beer, M. C., D. M. Durbin, L. Cai, A. Jonas, F. C. de Beer, and D. R. van der Westhuyzen. 2001. Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J. Lipid Res. 42: 309-313.
27. Temel, R. E., R. L. Walzem, C. L. Banka, and D. L. Williams. 2002. Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake. J. Biol. Chem. 277: 26565-26572.
28. Colvin, P. L., E. Moriguchi, P. H. Barrett, J. S. Parks, and L. L. Rudel 1999. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates. J. Lipid Res. 40: 1782-1792.
29. Colvin, P., E. Moriguchi, H. Barrett, J. Parks, and L. Rudel. 1998. Production rate determines plasma concentration of large high density lipoprotein in non-human primates. J. Lipid Res. 39: 2076-2085.
30. Colvin, P. L., and J. S. Parks. 1999. Metabolism of high density, lipoprotein subfractions. Curr. Opin. Lipidol. 10: 309-314.
31. Ueda, Y., E. Gong, L. Royer, P. N. Cooper, O. L. Francone, and E. M. Rubin. 2000. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J. Biol. Chem. 275: 20368-20373.
32. Oram, J. F., and A. M. Vaughan. 2000. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. Curr. Opin. Lipidol. 11: 253-260.
33. Wang, N., D. L. Silver, P. Costet, and A. R. Tall. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275:33053-33058.